World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
37429
World Ranking
11167
National Ranking
449

Overview

Geoffrey Liu is affiliated with the Princess Margaret Cancer Centre in Canada with a research focus centered on Medicine, particularly within Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research, and Surgery. Their work extensively covers topics related to lung cancer treatments, research studies, diagnosis, and treatment, along with cancer genomics, diagnostics, immunotherapy, and biomarkers, as well as studies on head and neck cancer and the application of radiomics and machine learning in medical imaging.

The scientist has contributed frequently to high-impact journals, with significant numbers of publications in the following venues:

  • Journal of Clinical Oncology (65 publications)
  • Journal of Thoracic Oncology (37 publications)
  • Annals of Oncology (31 publications)
  • Lung Cancer (29 publications)
  • Cancer Research (27 publications)

Geoffrey Liu's recent papers include notable works such as:

  • First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer (2020), New England Journal of Medicine
  • Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study (2024), Journal of Clinical Oncology
  • Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study (2022), The Lancet Respiratory Medicine
  • Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy (2021), Journal of Thoracic Oncology
  • Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization (2020), International Journal of Cancer

The scientist has collaborated frequently with several coauthors, including:

  • Natasha B. Leighl (102 collaborations)
  • Frances A. Shepherd (97 collaborations)
  • Adrian G. Sacher (85 collaborations)
  • Ming-Sound Tsao (82 collaborations)
  • Rayjean J. Hung (75 collaborations)

Geoffrey Liu's research areas span highly specialized subjects within lung cancer and cancer biology, highlighting an extensive focus on advanced lung cancer treatments and the molecular mechanisms underlying cancer persistence and resistance. Their research output and collaboration network reflect sustained contributions to these critical areas of clinical and translational cancer research.

Best Publications

  • Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Ranee Mehra;Daniel S W Tan

  • A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

    Rayjean J. Hung;James D. Mckay;Valerie Gaborieau;Paolo Boffetta

  • Patient preferences for oral versus intravenous palliative chemotherapy.

    G Liu;E Franssen;M I Fitch;E Warner

  • Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

    Annette McWilliams;Martin C. Tammemagi;John R. Mayo;Heidi Roberts

  • Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

    James D McKay;Rayjean J Hung;Younghun Han;Xuchen Zong

  • First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Todd M. Bauer;Filippo de Marinis;Enriqueta Felip

  • Sensitive tumour detection and classification using plasma cell-free DNA methylomes

    Shu Yi Shen;Rajat Singhania;Gordon Fehringer;Ankur Chakravarthy

  • Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

    Robert Carreras-Torres;Mattias Johansson;Philip C. Haycock;Kaitlin H. Wade

  • Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

    Alice T Shaw;Tae Min Kim;Lucio Crinò;Cesare Gridelli

  • Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

    Dong Wan Kim;Ranee Mehra;Daniel S W Tan;Enriqueta Felip

  • Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Yufei Wang;James D McKay;Thorunn Rafnar;Zhaoming Wang

  • XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy

    Sarada Gurubhagavatula;Geoffrey Liu;Sohee Park;Wei Zhou

  • Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

    Wei Zhou;Sarada Gurubhagavatula;Geoffrey Liu;Sohee Park

  • Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.

    Erin L. Stewart;Samuel Zhixing Tan;Geoffrey Liu;Ming-Sound Tsao

  • Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.

    Geeta Lal;Geoffrey Liu;Beverley Schmocker;Pardeep Kaurah

  • Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma

    Harvey I. Pass;Stephen M. Levin;Michael R. Harbut;Jonathan Melamed

  • Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors

    John T;Liu G;Tsao Ms

  • Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk

    Wei Zhou;Geoffrey Liu;David P Miller;Sally W Thurston

  • Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non-Small-Cell Lung Cancer Patients

    Wei Zhou;Rebecca S. Heist;Geoffrey Liu;Kofi Asomaning

  • Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium

    Darren R. Brenner;Paolo Boffetta;Eric J. Duell;Heike Bickeböller

Frequent Co-Authors

Wei Xu
Wei Xu Shenzhen University
David C. Christiani
David C. Christiani Harvard University
Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
Natasha B. Leighl
Natasha B. Leighl Princess Margaret Cancer Centre
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Rayjean J. Hung
Rayjean J. Hung Lunenfeld-Tanenbaum Research Institute
John C. Wain
John C. Wain Harvard University
Stig E. Bojesen
Stig E. Bojesen University of Copenhagen
Christopher I. Amos
Christopher I. Amos Baylor College of Medicine
Thomas J. Lynch
Thomas J. Lynch Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want flexible study options, there are several online programs that support various healthcare career paths. For registered nurses seeking career advancement, asn to fnp programs offer a bridge to become Family Nurse Practitioners, helping you move into advanced practice roles with a graduate degree.

Nutrition is a rapidly growing field, and those passionate about food science and wellness can explore the best online nutrition programs to launch or advance their careers. These programs cover essential topics like dietetics, human biology, and public health, and offer plenty of distance learning options.

Aspiring healthcare administrators should consider cahme accredited mha online programs, which are respected for their rigorous standards and prepare graduates for high-level leadership roles in hospitals, clinics, and other organizations.

Finally, registered nurses looking to build on their education might wonder, does rn to bsn require clinicals? Some online RN to BSN programs are designed to be completed without in-person clinicals, making them even more accessible for working professionals.

Best Scientists Citing Geoffrey Liu

Trending Scientists

Recently Published Articles